Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD

Keisuke Yaku, Sailesh Palikhe, Tooba Iqbal, Faisal Hayat, Yoshiyuki Watanabe, Shiho Fujisaka, Hironori Izumi, Tomoyuki Yoshida, Mariam Karim, Hitoshi Uchida, Allah Nawaz, Kazuyuki Tobe, Hisashi Mori, Marie E Migaud, Takashi Nakagawa

Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan. · pubmed

Paper

Abstract

Decreased nicotinamide adenine dinucleotide (oxidized form) (NAD

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Nicotinamide riboside and nicotinamide mononucleotide enhance NAD levels, which may have implications for aging and age-related diseases. The paper addresses the role of NAD in cellular metabolism and its potential to influence longevity, making it relevant to the root causes of aging.

Author of this paper? Send a correction.